NCT01924754View on ClinicalTrials.gov

Gardasil Immunogenicity With Needle-Free Injection

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
HPV Seroconversion
Trial Locations (2)

94062

University of California, San Francisco, San Francisco

Unknown

Thai Red Cross AIDS Research Centre, Bangkok

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of California, San Francisco

OTHER

NCT01924754 - Gardasil Immunogenicity With Needle-Free Injection | Biotech Hunter | Biotech Hunter